Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR

Journal of Clinical Microbiology

Volumn 38, Issue 9, 2000, Pages 3156-3160

  Loparev, V N ^a   Argaw, T ^a   Krause, P R ^a   Takayama, M ^a   Schmid, D S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; VIRUS DNA;

ARTICLE; ENZYME ACTIVE SITE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STRAIN DIFFERENCE; VARICELLA ZOSTER VIRUS; VIRUS CHARACTERIZATION;

DNA VIRUSES; HUMAN HERPESVIRUS 3;

EID: 0033823660     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.9.3156-3160.2000     Document Type: Article

References (30)

1. Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates
2. Live attenuated varicella vaccine
3. Experience and reason: Twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine
4. The complete DNA sequence of varicella-zoster virus
5. Viral infections in severely immunocompromised cancer patients
6. Fatal chickenpox pneumonia in an asthmatic patient on oral steroids and methotrexate
7. Varicella-zoster virus: Prospects for control
8. Varicella-zoster virus
9. Varicella vaccine: The American experience
10. A multicentre trial of live attenuated varicella vaccine in children with leukaemia in remission
11. Immunization of healthy adults with live attenuated varicella vaccine
12. The incidence of zoster after immunization with live attenuated varicella vaccine: A study in children with leukemia
13. Analysis of United Kingdom wild-type strains of varicella-zoster virus: Differentiation from the Oka vaccine strain
14. Molecular epidemiology of varicella-zoster virus in East London, England, between 1971 and 1995
15. Analysis of varicella-zoster virus DNAs of clinical isolates by endonuclease HpaI
16. Distribution of varicella-zoster virus strains carrying a Pst-site-less mutation in Japan and DNA change responsible for the mutation
17. Oka/Merck varicella vaccine in healthy children: Final report of a 2-year efficacy study and 7-year follow-up studies
18. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates
19. Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world
20. Identification of the Oka strain of the live attenuated varicella vaccine from other clinical isolates by molecular epidemiologic analysis
21. Detection of herpes simplex and varicella-zoster infection from cutaneous lesions in different clinical stages with the polymerase chain reaction
22. Primary varicella in adult renal transplant recipients: A report of three cases plus a review of the literature
23. Varicella vaccine
24. Differentiation of oka varicella vaccine strain from wild varicella-zoster virus strains isolated from vaccinees and household contact
25. Genome differences among varicella-zoster virus isolates
26. Identification of varicella-zoster virus strains by PCR analysis of three repeat elements and a PstI-site-less region
27. Clinical overview of varicella vaccine: Development and early studies
28. High incidence of breakthrough varicella observed in healthy Japanese children immunized with live attenuated varicella vaccine (Oka strain)
29. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine
30. Analysis of strain variation of R1 repeated structure in varicella-zoster virus DNA by polymerase chain reaction